Robin Hume

869 total citations
21 papers, 363 citations indexed

About

Robin Hume is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, Robin Hume has authored 21 papers receiving a total of 363 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hematology, 5 papers in Genetics and 4 papers in Oncology. Recurrent topics in Robin Hume's work include Hematopoietic Stem Cell Transplantation (16 papers), Acute Myeloid Leukemia Research (15 papers) and Blood disorders and treatments (5 papers). Robin Hume is often cited by papers focused on Hematopoietic Stem Cell Transplantation (16 papers), Acute Myeloid Leukemia Research (15 papers) and Blood disorders and treatments (5 papers). Robin Hume collaborates with scholars based in United States, United Kingdom and Germany. Robin Hume's co-authors include Paul G. Richardson, Bijan Nejadnik, Brandon M. Triplett, Robert J. Soiffer, Nancy A. Kernan, Joseph H. Antin, Stephan A. Grupp, Leslie Lehmann, Angela R. Smith and Massimo Iacobelli and has published in prestigious journals such as Journal of Clinical Oncology, Blood and British Journal of Haematology.

In The Last Decade

Robin Hume

20 papers receiving 357 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robin Hume United States	8	259	77	63	49	48	21	363
Lisa Brennan United States	8	295 1.1×	125 1.6×	29 0.5×	32 0.7×	42 0.9×	14	590
Bensinger Wi United States	12	267 1.0×	120 1.6×	34 0.5×	33 0.7×	27 0.6×	18	348
Xavier López‐Karpovitch Mexico	12	260 1.0×	58 0.8×	97 1.5×	19 0.4×	27 0.6×	48	377
Maurits C. F. J. de Rotte Netherlands	10	155 0.6×	31 0.4×	137 2.2×	31 0.6×	24 0.5×	15	393
Sergio Mecarocci Italy	11	116 0.4×	191 2.5×	53 0.8×	21 0.4×	41 0.9×	22	432
J Pizzuto Mexico	11	164 0.6×	80 1.0×	66 1.0×	46 0.9×	32 0.7×	39	373
Francesco Barbato Italy	8	106 0.4×	75 1.0×	45 0.7×	15 0.3×	11 0.2×	20	318
MC Poon Canada	13	362 1.4×	88 1.1×	36 0.6×	24 0.5×	20 0.4×	26	482
G. Lercari Italy	12	258 1.0×	75 1.0×	38 0.6×	20 0.4×	20 0.4×	32	398
J-H Bourhis France	12	285 1.1×	137 1.8×	95 1.5×	34 0.7×	23 0.5×	15	447

Countries citing papers authored by Robin Hume

Since Specialization

Citations

This map shows the geographic impact of Robin Hume's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robin Hume with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robin Hume more than expected).

Fields of papers citing papers by Robin Hume

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robin Hume. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robin Hume. The network helps show where Robin Hume may publish in the future.

Co-authorship network of co-authors of Robin Hume

This figure shows the co-authorship network connecting the top 25 collaborators of Robin Hume. A scholar is included among the top collaborators of Robin Hume based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robin Hume. Robin Hume is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kernan, Nancy A., Stephan A. Grupp, Angela R. Smith, et al.. (2018). Final results from a defibrotide treatment‐IND study for patients with hepatic veno‐occlusive disease/sinusoidal obstruction syndrome. British Journal of Haematology. 181(6). 816–827. 89 indexed citations

Richardson, Paul G., Joseph H. Antin, Sergio Giralt, et al.. (2018). Adults Receiving Defibrotide for the Treatment of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) after Hematopoietic Stem Cell Transplantation (HSCT): Final Results From the Expanded-Access Program (T-IND). Biology of Blood and Marrow Transplantation. 24(3). S300–S301. 1 indexed citations

Kernan, Nancy A., Paul G. Richardson, Angela R. Smith, et al.. (2018). Defibrotide for the treatment of hepatic veno‐occlusive disease/sinusoidal obstruction syndrome following nontransplant‐associated chemotherapy: Final results from a post hoc analysis of data from an expanded‐access program. Pediatric Blood & Cancer. 65(10). e27269–e27269. 23 indexed citations

Richardson, Paul G., Angela R. Smith, Brandon M. Triplett, et al.. (2017). Defibrotide for Patients with Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome: Interim Results from a Treatment IND Study. Biology of Blood and Marrow Transplantation. 23(6). 997–1004. 44 indexed citations

Kernan, Nancy A., Paul G. Richardson, Brandon M. Triplett, et al.. (2017). Efficacy and safety of defibrotide (DF) to treat hepatic veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS) after primary chemotherapy (CT): A post hoc analysis of final data.. Journal of Clinical Oncology. 35(15_suppl). 10513–10513. 2 indexed citations

Grupp, Stephan A., Paul G. Richardson, Angela R. Smith, et al.. (2017). Timing of initiation of defibrotide (DF) post-diagnosis of hepatic veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS) after hematopoietic stem cell transplantation (HSCT): Final data from an expanded-access protocol.. Journal of Clinical Oncology. 35(15_suppl). 7047–7047. 2 indexed citations

Richardson, Paul G., Angela R. Smith, Brandon M. Triplett, et al.. (2017). Earlier defibrotide initiation post‐diagnosis of veno‐occlusive disease/sinusoidal obstruction syndrome improves Day +100 survival following haematopoietic stem cell transplantation. British Journal of Haematology. 178(1). 112–118. 61 indexed citations

Strouse, Christopher, Paul G. Richardson, Grant Prentice, et al.. (2016). Defibrotide for Treatment of Severe Veno-Occlusive Disease in Pediatrics and Adults: An Exploratory Analysis Using Data from the Center for International Blood and Marrow Transplant Research. Biology of Blood and Marrow Transplantation. 22(7). 1306–1312. 40 indexed citations

Corbacioglu, Selim, Enric Carreras, Mohamad Mohty, et al.. (2016). Defibrotide for the Treatment of Hepatic Veno-Occlusive Disease: Final Results From the International Compassionate-Use Program. Biology of Blood and Marrow Transplantation. 22(10). 1874–1882. 58 indexed citations

10.

Kernan, Nancy A., Stephan A. Grupp, Kamalika Banerjee, et al.. (2016). Pooled Treatment Analysis of Pediatric Patients with Defibrotide for Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome and Multi-Organ Dysfunction Following Hematopoietic Stem Cell Transplant. Biology of Blood and Marrow Transplantation. 22(3). S188–S189.

11.

Richardson, Paul G., Brandon M. Triplett, Nancy A. Kernan, et al.. (2016). Early Initiation of Defibrotide in Patients with Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome Following Hematopoietic Stem Cell Transplantation Improves Day +100 Survival. Biology of Blood and Marrow Transplantation. 22(3). S82–S83. 2 indexed citations

12.

Grupp, Stephan A., Angela R. Smith, Brandon M. Triplett, et al.. (2016). Timing of Initiation of Defibrotide Post-Diagnosis of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome Post-Hematopoietic Stem Cell Transplantation: Exploratory Age-Group Analysis from an Expanded Access Study. Blood. 128(22). 66–66. 3 indexed citations

13.

Richardson, Paul G., Angela R. Smith, Brandon M. Triplett, et al.. (2015). Updated Results from the Ongoing US Treatment IND Study Using Defibrotide for Patients with Hepatic Veno-Occlusive Disease. Biology of Blood and Marrow Transplantation. 21(2). S109–S110. 3 indexed citations

14.

Kernan, Nancy A., Paul G. Richardson, Angela R. Smith, et al.. (2015). Defibrotide for the Treatment of Patients with Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome with/without Multi-Organ Dysfunction Following Chemotherapy: Results from an Ongoing Expanded Access Program. Blood. 126(23). 3121–3121. 1 indexed citations

15.

Corbacioglu, Selim, Enric Carreras, Mohamad Mohty, et al.. (2015). Defibrotide for the Treatment of Hepatic Veno-Occlusive Disease: An Update from the International Compassionate Use Program in 710 Patients. Biology of Blood and Marrow Transplantation. 21(2). S108–S108. 6 indexed citations

16.

Corbacioglu, Selim, Enric Carreras, Mohamad Mohty, et al.. (2014). Defibrotide for the Treatment of Hepatic Veno-Occlusive Disease: An Update from the International Compassionate Use Program in 710 Patients. Blood. 124(21). 1138–1138. 2 indexed citations

17.

Corbacioglu, Selim, Enric Carreras, Dietger Niederwieser, et al.. (2010). Safety of Defibrotide (DF) In Stem Cell Transplant (SCT) Patients (Pts).. Blood. 116(21). 3482–3482. 4 indexed citations

18.

James, W. B., et al.. (1970). A comparison of three substances used for bowel preparation prior to radiological examination. Clinical Radiology. 21(2). 201–202. 13 indexed citations

19.

James, W. B., et al.. (1970). A comparison of two substances for colonic lavage. British Journal of Radiology. 43(514). 743–744. 1 indexed citations

20.

Hume, Robin, et al.. (1968). Refractory anaemia with dysproteinaemia: response to small doses of steroid.. PubMed. 15(3). 326–326. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact